Home » preclinical

Iris Pharma is a French Contract Research Organization (CRO) dedicated to preclinical studies, (non-clinical research) and clinical trials in ophthalmology.

Founded in 1989 by Pierre-Paul Elena, Ph.D., Iris Pharma provides drug development services to Biotechnology and Pharmaceutical Industries (from early stage of preclinical research to Phase 1-4 clinical research). It is formed of groups in three areas of complementary activities using the latest apparatus.

Preclinical studies and in-depth research

Iris Pharma provides :

• Preclinical studies in ophthalmology: a unit managing the complete animal development of drugs and devices.
• Basic preclinical studies in ophthalmology: customized studies for new drugs, devices, and methods development.
• Analytical testing laboratory: a technical environment dedicated to the bioanalytical testing of the products.

Preclinical studies and a complete range of services

Iris Pharma's Research Department never stops exploring: preclinical studies in ophthalmology, studies related to glaucoma, pharmacokinetic studies, retinopathy research, ocular drug efficacy studies etc.